Literature DB >> 7066883

Methotrexate levels in the interstitial space and seminiferous tubule of rat testis.

R Riccardi, R A Vigersky, S Barnes, W A Bleyer, D G Poplack.   

Abstract

The ability of methotrexate (MTX) to pass from the blood into the interstitial space and seminiferous tubule of the rat was investigated using testicular micropuncture. MTX was administered to anesthetized adult Wister rats via a femoral vein cannula. Constant plasma levels of MTX were achieved by giving a priming dose followed by a constant infusion of 1, 10, or 100 mg/kg/hr with 6 to 27 rats studied at each dose. Blood (via a jugular vein cannula), testicular interstitial fluid, and seminiferous tubule fluid (via direct micropuncture) were periodically sampled during the 4 hr of drug infusion. Under steady-state conditions, when compared to corresponding plasma values, MTX levels were 2- to 4-fold lower in the testicular interstitial fluid and 18- to 50-fold lower in the seminiferous tubule. These results indicate that, in the rat, a significant blood-testis barrier to MTX exists at the tubular but probably not at the capillary-interstitial level. If these results can be extrapolated to humans, they do not provide a pharmacological explantation for the frequent occurrence of leukemic relapse in the interstitium of the testes in boys with acute lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066883

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia.

Authors:  R G Grundy; A D Leiper; R Stanhope; J M Chessells
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

2.  Current issues in the management of children with acute lymphocytic leukaemia.

Authors:  D Pinkel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 3.  The Good, the Bad and the Ugly of Testicular Immune Regulation: A Delicate Balance Between Immune Function and Immune Privilege.

Authors:  Gurvinder Kaur; Kandis Wright; Saguna Verma; Allan Haynes; Jannette M Dufour
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Drugs in semen.

Authors:  S Pichini; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

5.  Is the testis a chemo-privileged site? Is there a blood-testis barrier?

Authors:  Dhiren S Dave; John T Leppert; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

6.  Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Authors:  Yiying Huang; Md Tozammel Hoque; Mohammad-Ali Jenabian; Kishanda Vyboh; Sana-Kay Whyte; Nancy L Sheehan; Pierre Brassard; Maud Bélanger; Nicolas Chomont; Courtney V Fletcher; Jean-Pierre Routy; Reina Bendayan
Journal:  J Antimicrob Chemother       Date:  2016-04-13       Impact factor: 5.790

7.  Testicular metastasis in a case of squamous cell carcinoma of the lung.

Authors:  Dennis Andrew Buck; Robert H Byrd; Cynthia L Holmes; Theodore Pollock
Journal:  Case Rep Oncol       Date:  2015-03-03

8.  Bilateral Testicular Metastases from Lung Adenocarcinoma Showing an Objective Response to Nivolumab: A Case Report and Review of the Literature.

Authors:  Taichi Ozeki; Keiichi Fujiwara; Atsushi Shimonishi; Jun Nishimura; Sachi Okawa; Kenji Takada; Hiroe Kayatani; Daisuke Minami; Ken Sato; Takuo Shibayama
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

Review 9.  Role of chemotherapy prior to orchiectomy in metastatic testicular cancer-is testis really a sanctuary site?

Authors:  B Vinusha Reddy; A Sivakanth; G Naveen Babu; Krishnamurthy Swamyvelu; Yg Basavana Goud; Ba Madhusudhana; Vasu Reddy Challa
Journal:  Ecancermedicalscience       Date:  2014-02-27

Review 10.  Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.

Authors:  Nikolaos Tsesmetzis; Cynthia B J Paulin; Sean G Rudd; Nikolas Herold
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.